Endothelial function as a therapeutic target in coronary artery disease.

N. Sharma, T. C. Andrews

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In healthy individuals, endothelial cells regulate a host of functions including vasomotor tone, thrombosis/ fibrinolysis, and cell-cell interactions. The development of endothelial dysfunction may be a common pathway by which cardiovascular risk factors impact plaque formation, growth, and rupture. Many pharmacologic and nonpharmacologic interventions known to decrease cardiovascular risk also improve endothelial function. For these reasons, some have suggested that improvement in endothelial function may be an important therapeutic target in the treatment of coronary artery disease.

Original languageEnglish (US)
Pages (from-to)303-307
Number of pages5
JournalCurrent Atherosclerosis Reports
Volume2
Issue number4
StatePublished - Jul 2000

Fingerprint

Fibrinolysis
Cell Communication
Coronary Artery Disease
Rupture
Thrombosis
Endothelial Cells
Growth
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Endothelial function as a therapeutic target in coronary artery disease. / Sharma, N.; Andrews, T. C.

In: Current Atherosclerosis Reports, Vol. 2, No. 4, 07.2000, p. 303-307.

Research output: Contribution to journalArticle

Sharma, N. ; Andrews, T. C. / Endothelial function as a therapeutic target in coronary artery disease. In: Current Atherosclerosis Reports. 2000 ; Vol. 2, No. 4. pp. 303-307.
@article{d5fb029c74764169936b00af321f4980,
title = "Endothelial function as a therapeutic target in coronary artery disease.",
abstract = "In healthy individuals, endothelial cells regulate a host of functions including vasomotor tone, thrombosis/ fibrinolysis, and cell-cell interactions. The development of endothelial dysfunction may be a common pathway by which cardiovascular risk factors impact plaque formation, growth, and rupture. Many pharmacologic and nonpharmacologic interventions known to decrease cardiovascular risk also improve endothelial function. For these reasons, some have suggested that improvement in endothelial function may be an important therapeutic target in the treatment of coronary artery disease.",
author = "N. Sharma and Andrews, {T. C.}",
year = "2000",
month = "7",
language = "English (US)",
volume = "2",
pages = "303--307",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Endothelial function as a therapeutic target in coronary artery disease.

AU - Sharma, N.

AU - Andrews, T. C.

PY - 2000/7

Y1 - 2000/7

N2 - In healthy individuals, endothelial cells regulate a host of functions including vasomotor tone, thrombosis/ fibrinolysis, and cell-cell interactions. The development of endothelial dysfunction may be a common pathway by which cardiovascular risk factors impact plaque formation, growth, and rupture. Many pharmacologic and nonpharmacologic interventions known to decrease cardiovascular risk also improve endothelial function. For these reasons, some have suggested that improvement in endothelial function may be an important therapeutic target in the treatment of coronary artery disease.

AB - In healthy individuals, endothelial cells regulate a host of functions including vasomotor tone, thrombosis/ fibrinolysis, and cell-cell interactions. The development of endothelial dysfunction may be a common pathway by which cardiovascular risk factors impact plaque formation, growth, and rupture. Many pharmacologic and nonpharmacologic interventions known to decrease cardiovascular risk also improve endothelial function. For these reasons, some have suggested that improvement in endothelial function may be an important therapeutic target in the treatment of coronary artery disease.

UR - http://www.scopus.com/inward/record.url?scp=0034230987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034230987&partnerID=8YFLogxK

M3 - Article

C2 - 11122758

AN - SCOPUS:0034230987

VL - 2

SP - 303

EP - 307

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 4

ER -